SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tim Zhu who wrote (95)7/8/1996 4:57:00 PM
From: Patrick Tang   of 849
 
Tim: Don't look back. I had similar experiences many, many times and I am still alive and well and TRADING. I learned not to marry to any stock because I believe that this type of relationship will ultimately lead to financial impotence.

Fundementally, your accessment of the NMPS's business prospect is sound. I believe what drags down the shares price is the mishandling of the secondary offering. They have, according to its annual report, more than $11 millions under their kitchen sink and they do NOT have to dilute their shares by PPO. I hope that these jokers have learned their lessons the hard way because they are shareholders themselves too. Well, that's history and I don't want to comment on it any more.

After todays announcement, NMPS shares moved up ONLY 7.8 %. That's very modest in view of the market potentials. Maybe a combination of the following reasons results in its small price movement:

1. PPO. This is a very dirty 3-lettered word for ANY stock. Maybe the NMPS management will withdraw this damned thing to support the share price (this is strictly my wishful thinking since I am now a shareholder).

2. Sell-on-news syndrome prevailed again. People will ask: what's for the encore? With the absence of further news, many just bailed out.

3. The general market is in the middle of a HUGH correction before rally towards the general election in November. You could find blood-letting everywhere, including many sound biotechs.

However, against this bearish background, the technical stuff for NMPS remains BULLISH:

1. It tested its phase 2 bottom ($9.5) and held and during the process, it made HIGHER lows.

2, The volume pattern looks good. Since the June 26 bottom at $9.50 (946,500 shares), volume had been in a decreasing trend until today (1,334,900). This pattern suggests that specialist has already finished selling off his inventory for a profit and will start accumulating again. Normally, this calls for a price correction so that he can replenish his inventory at lower prices. However, against a bullish product approval, he might has ALREADY accumulated shares TODAY in anticipations of more positive news from the company and the so-called security analysts. I believe the specialist knows something that we don't. Well, only time will tell.

3. It is comfortably above its 200-days moving average

In summary, I believe once the overhang clouds (PPO and sell-on news) have been cleared, NMPS will fly. So Tim, look forward and cheer up. $31 is still a reasonable target.

******** -20 and counting!

Best wishes.

Note: BTGC looks promising. Watch out for its price/voloume actions at around $9.00. Good luck.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext